VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials-Reference-Cited by-同舟云学术

VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials

Published:2012-07 Issue:7 Volume:13 Page:724-733
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Lambrechts Diether,Claes Bart,Delmar Paul,Reumers Joke,Mazzone Massimiliano,Yesilyurt Betül T,Devlieger Roland,Verslype Chris,Tejpar Sabine,Wildiers Hans,de Haas Sanne,Carmeliet Peter,Scherer Stefan J,Van Cutsem Eric

Publisher

Elsevier BV

Subject

Oncology

Reference35 articles.

1. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

2. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer;Sandler;N Engl J Med,2006

3. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer;Miller;N Engl J Med,2007

4. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial;Escudier;Lancet,2007

5. Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma;Kreisl;J Clin Oncol,2009

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients;npj Genomic Medicine;2024-05-29

2. Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab;Clinical Pharmacology & Therapeutics;2023-06-21

3. Biomarker analysis of the phase II JO25567 study comparing erlotinib with or without bevacizumab in first-line advanced EGFR+ non-small-cell lung cancer;Translational Lung Cancer Research;2023-06

4. Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma;Cancers;2023-01-05

5. The Association of Biochemical and Genetic Biomarkers in VEGF Pathway with Depression;Pharmaceutics;2022-12-09